Guggenheim Capital’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-46,517
Closed -$54.9K 1643
2025
Q1
$54.9K Sell
46,517
-7,943
-15% -$12.2K ﹤0.01% 1625
2024
Q4
$99.7K Sell
54,460
-17,703
-25% -$34.6K ﹤0.01% 1655
2024
Q3
$123K Sell
72,163
-117,661
-62% -$193K ﹤0.01% 1818
2024
Q2
$260K Sell
189,824
-37,702
-17% -$76.1K ﹤0.01% 1689
2024
Q1
$853K Buy
227,526
+32,149
+16% +$188K 0.01% 1262
2023
Q4
$1.92M Buy
195,377
+43,021
+28% +$352K 0.01% 863
2023
Q3
$1.27M Sell
152,356
-75,735
-33% -$866K 0.01% 993
2023
Q2
$3.03M Sell
228,091
-35,293
-13% -$429K 0.02% 695
2023
Q1
$3.05M Sell
263,384
-17,912
-6% -$178K 0.03% 706
2022
Q4
$2.3M Sell
281,296
-35,551
-11% -$306K 0.02% 804
2022
Q3
$1.84M Sell
316,847
-7,529
-2% -$43.2K 0.02% 874
2022
Q2
$1.43M Sell
324,376
-125,732
-28% -$764K 0.01% 1051
2022
Q1
$4.1M Buy
450,108
+31,330
+7% +$361K 0.02% 726
2021
Q4
$8.57M Buy
418,778
+81,136
+24% +$1.96M 0.04% 488
2021
Q3
$8.63M Buy
337,642
+331,309
+5,231% +$9.82M 0.05% 438
2021
Q2
$221K Buy
+6,333
New +$184K ﹤0.01% 2114
2019
Q4
Sell
-14,080
Closed -$73K 2140
2019
Q3
$73K Sell
14,080
-17,943
-56% -$100K ﹤0.01% 2074
2019
Q2
$194K Buy
32,023
+127
+0.4% +$891 ﹤0.01% 2037
2019
Q1
$231K Buy
+31,896
New +$231K ﹤0.01% 2013

Other funds holding PACB